“…The main characteristics of NPs are low toxicity, modulation of pharmacokinetics, increased bioavailability, and the possibility of transporting pharmacological components, which also allows the drug to be delivered directly to the specific target ( Khalil et al, 2013 ; Torres-Santiago et al, 2016 ). Nanoparticles with silver inserts in their structure, called silver nanoparticles (AgNp), are used for health applications because they have antimicrobial and anti-inflammatory activities ( Shrivastava et al, 2007 ; Adair, 2009 ; Pourali and Yahyaei, 2016 ; Scandorieiro et al, 2016 ) described in Gram-negative and Gram-positive bacteria, including multidrug-resistant strains ( Shrivastava et al, 2007 ; Durán et al, 2016 ; Scandorieiro et al, 2016 ), protozoa as Leishmania ( Allahverdiyev et al, 2011 ; Fanti et al, 2018 ; Isaac-Márquez et al, 2018 ), some virus ( Park et al, 2018 ; Sharma et al, 2019 ), and filamentous fungi ( Sanguiñedo et al, 2018 ). In addition, AgNp is able to accumulate in tissues, probably reaching cysts of T. gondii ( Adeyemi and Sulaiman, 2015 ).…”